Does RISANKIZUMAB Cause Psoriasis? 138 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Psoriasis have been filed in association with RISANKIZUMAB (Skyrizi). This represents 5.2% of all adverse event reports for RISANKIZUMAB.
138
Reports of Psoriasis with RISANKIZUMAB
5.2%
of all RISANKIZUMAB reports
2
Deaths
25
Hospitalizations
How Dangerous Is Psoriasis From RISANKIZUMAB?
Of the 138 reports, 2 (1.4%) resulted in death, 25 (18.1%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Psoriasis Listed in the Official Label?
Yes, Psoriasis is listed as a known adverse reaction in the official FDA drug label for RISANKIZUMAB.
What Other Side Effects Does RISANKIZUMAB Cause?
Product storage error (396)
Drug ineffective (206)
Crohn's disease (103)
Arthralgia (100)
Off label use (100)
Product temperature excursion issue (88)
Diarrhoea (72)
Fatigue (70)
Rash (64)
Pruritus (61)
What Other Drugs Cause Psoriasis?
SECUKINUMAB (21,976)
APREMILAST (19,255)
ADALIMUMAB (16,698)
ETANERCEPT (10,818)
RISANKIZUMAB-RZAA (6,896)
METHOTREXATE (6,283)
USTEKINUMAB (4,955)
INFLIXIMAB (3,524)
CERTOLIZUMAB PEGOL (3,428)
IXEKIZUMAB (2,818)
Which RISANKIZUMAB Alternatives Have Lower Psoriasis Risk?
RISANKIZUMAB vs RISANKIZUMAB-RZAA
RISANKIZUMAB vs RISDIPLAM
RISANKIZUMAB vs RISEDRONATE
RISANKIZUMAB vs RISEDRONIC ACID
RISANKIZUMAB vs RISPERDAL